Eco R1 Capital, LLC Apellis Pharmaceuticals, Inc. Put Options Transaction History
Eco R1 Capital, LLC
- $2.31 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding APLS
# of Institutions
308Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$517 Million0.08% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$369 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$326 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$192 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.4MShares$146 Million4.68% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.65B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...